Enter your terms above and click the 'Search' button.

Showing articles 0 to 9 of 9 Filter Applied: nivolumab (Click to remove) A 48-Year-Old Woman with 6 Months of Vivid Visual Hallucinations Neurol 99:166-171, Kizza, J.,et al, 2022 Autoimmune Encephalitis Related to Cancer Treatment with Immune Checkpoint Inhibitors Neurol 97:e191-e202, Nersesjan, V.,et al, 2021 Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum Ann Neurol 87:659-669, Dubey, D.,et al, 2020 Immune Checkpoint Inhibitor-Related Myositis and Myocarditis in Patients with Cancer Neurol 91:e985-e994, Touat, M.,et al, 2018 Nivolumab-Induced Autoimmune Encephalitis in Two Patients with Lung Adenocarcinoma Case Rep Neurol Med 2018;doi:10.1155/2018/2548528, Shah, S.,et al, 2018 Neuromuscular Adverse Events Associated with Anti-PD-1 Monoclonal Antibodies Neurol 92:663-674, Johansen, A.,et al, 2019 Acute demyelinating polyneuropathy induced by nivolumab JNNP 89:435-437, Fukumoto, Y.,et al, 2018 Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain NEJM 379:722-730,789, Tawbi, H.A.,et al, 2018 Progressive Multifocal Leukoencephalopathy after Treatment with Nivolumab Emerg Inf Dis 24:1594-1596, Martinot, M.,et al, 2018 Showing articles 0 to 9 of 9